簡單算一下超過100萬股,而且從6.16元開始拋,愈拋愈便宜,拋到昨天只剩4塊多還在拋。然後今天出了一個負面影響,我會好奇Flynn james是不是提前知道了什麼...查看全文
牛唐2019-05-30 14:25
$Aclaris Therapeutics(ACRS)$ $Liquidia技术(LQDA)$ $Acer医疗(ACER)$ 最近大盘不好,关注下这些本身处于低位,又有临近催化剂的医药股查看全文
flamingoz2019-05-15 16:07
昨日看了看$Aclaris Therapeutics(ACRS)$ ,JAK抑制剂治雄脱似乎有一点眉目,这可是个巨大市场。但想了一下,应该也不会有振奋的成果,最出名的JAK1/JAK3托法替布,用药样本那么大,里面的自身免疫病患者里肯定有脱发的,要是治雄脱有效,肯定有些患者用着用着就回春了,然而辉瑞那边从来没有发现...查看全文
基岩研究院2019-05-10 13:46
前言
ACRS$Aclaris Therapeutics(ACRS)$是一家致力于皮肤科和免疫炎症药物开发和商业化的生物制药公司,早年凭借着头号产品A-101上市,目前拥有两个已获批产品Eskata和Rhofade。当然公司的发展不会止步于此,其最大的看点来自丰富的防脱产品线:ATI-502/ATI-501,临床进展顺利,有望成为首个局...查看全文
牛唐2019-05-01 17:40
$Aclaris Therapeutics(ACRS)$ 6月之前集中公布治疗脱发和白癜风的topline data,药物有快速通道认定,且过往数据较好,更重要的是股价处于低位,近期可以逢低买入查看全文
$Aclaris Therapeutics(ACRS)$ SC 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001086364-24-008117 Act: 34 Size: 12 KB 网页链接
$Aclaris Therapeutics(ACRS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001373604-24-000045 Size: 9 KB 网页链接
$Aclaris Therapeutics(ACRS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-019172 Size: 9 KB 网页链接
$Aclaris Therapeutics(ACRS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001373604-24-000042 Size: 10 KB 网页链接
$Aclaris Therapeutics(ACRS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001373604-24-000035 Size: 10 KB 网页链接
$Aclaris Therapeutics(ACRS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016192 Size: 8 KB 网页链接
$Aclaris Therapeutics(ACRS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016195 Size: 7 KB 网页链接
$Aclaris Therapeutics(ACRS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016193 Size: 8 KB 网页链接
$Aclaris Therapeutics(ACRS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016194 Size: 8 KB 网页链接
$Aclaris Therapeutics(ACRS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-016197 Size: 8 KB 网页链接